University of Minnesota Office for Technology Commercialization

Submit a New Inquiry

Technology #20160410-20170196 - Adaptive Immune Response Stimulated with TLR8 and Dual TLR7/TLR8 Agonists

University of Minnesota Office for Technology Commercialization contracts with Nouvant to provide this service.

Your inquiry will be sent to this technology's managers. All fields are required unless otherwise noted.

Optional

Optional

By submitting this inquiry you accept the terms of the Privacy Policy and Terms of Service.

Powered by Nouvant